Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNMT | P11086 | 1/20 | 0.38 |
| ▸ | DRD2 | P14416 | 1/20 | 0.36 |
| ▸ | DRD4 | P21917 | 1/20 | 0.36 |
| ▸ | DRD3 | P35462 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1115874 | 0.91 | PNMT (0.35) | PNMTDRD2DRD4DRD3NPC1 | |
| Hydrochloric Acid SCHEMBL1116208 | 0.90 | PNMT (0.36) | PNMTDRD2DRD4DRD3NPC1 | |
| Hydrochloric Acid SCHEMBL1115759 | 0.89 | PNMT (0.33) | PNMTDRD2DRD4DRD3NPC1 | |
| Hydrochloric Acid SCHEMBL1115905 | 0.89 | PNMT (0.33) | PNMTDRD2DRD4DRD3NPC1 | |
| Iodide SCHEMBL7931462 | 0.88 | PNMT (0.36) | PNMTDRD2DRD4DRD3NPC1 | |
| Hydrochloric Acid SCHEMBL1116193 | 0.83 | PNMT (0.37) | PNMTDRD2DRD4DRD3NPC1 | |
| Hydrochloric Acid SCHEMBL395592 | 0.78 | PNMT (0.52) | PNMTDRD2DRD4DRD3NPC1 | |
| Hydrochloric Acid SCHEMBL31522665 | 0.78 | PNMT (0.52) | PNMTDRD2DRD4DRD3NPC1 | |
| SCHEMBL7034057 | 0.74 | PNMT (0.49) | PNMTDRD2DRD4DRD3NPC1 | |
| Bromide SCHEMBL1821843 | 0.74 | PNMT (0.52) | PNMTDRD2DRD4DRD3NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110065876-A1 | ALUMINUM PHENOXIDE COMPOUND AND PROCESS FOR PRODUCING STABILIZED POLYMER BY USING THE SAME | ADEKA CORPORATION (JP) | 2011-03-17 | — | — | US | disclosed |
| EP-2281825-A1 | ALUMINUM PHENOXIDES AND PROCESS FOR PRODUCTION OF STABILIZED POLYMERS BY USING THE ALUMINUM PHENOXIDES | Adeka Corporation (JP) | 2011-02-09 | — | — | EP | disclosed |
| US-6870015-B2 | Catalyst component for addition polymerization, process for producing catalyst for addition polymerization and process for producing addition polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-03-22 | — | — | US | disclosed |
| EP-1300425-A2 | Catalyst component for addition polymerization, process for producing said catalyst and process for producing addition polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2003-04-09 | — | — | EP | disclosed |
| US-20030060579-A1 | Catalyst component for addition polymerization, process for producing catalyst for addition polymerization and process for producing addition polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2003-03-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110065876-A1 | ALUMINUM PHENOXIDE COMPOUND AND PROCESS FOR PRODUCING STABILIZED POLYMER BY USING THE SAME | ALOX12, ALOX5AP, ALOX5 | PNMT 292/4885DRD2 2705/4885DRD4 2089/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.